|
Left Zone Top | |
|
|
| |
Join, share, learn and collaborate 54 leading life science organisations, and growing. Celebrating 10 Years Shaping the Future of Pharmacovigilance |
| |
|
| |
Find out more... |
pvnet |
pvconnect |
|
|
News
Page Content 2011 | Archive
The complex business of simplification Friday, December 02, 2011 Building emerging markets BRIC by BRIC Monday, October 03, 2011 A forum for Heads of Medical Affairs Thursday, September 01, 2011 The Generic Formulation Friday, July 15, 2011 Keeping the Supply Chain Agile Monday, May 23, 2011 Navigating the perfect storm Monday, March 21, 2011 Quality Management: Let's make it simpler Tuesday, January 25, 2011 WCI focus on the challenges of risk management in biopharmaceuticals Tuesday, January 18, 2011 "Together we will quickly progress to be seen as the first port of call for a range of business critical issues" Monday, January 10, 2011
 |
|
|
|
|
- "The first manet forum demonstrated the value that can be gained from getting together and discussing the challenges that we all face on a daily basis. I\'m convinced that manet will enable operational improvements in our Medical Affairs actitivities"Matthias Müller, SVP Medical Affairs Europe and Australia, Grünenthal
- "WCI\'s experience and knowledge has made a key contribution to the change management process at Nycomed. Their ability to remain focused and work to important timelines has enabled the organisation to move a step closer to its vision"Betina Østergaard Eriksen, VP International Drug Safety, Nycomed
- "The combination of WCI and Sidley Austin LLP\'s depth of experience provides not only a thorough understanding of compliance risks, but also a systems based perspective on how to manage these risks with a view to both current and future regulations"Scott Bass, Partner, Sidley Austin LLP
- "More than just benchmarking, pvnet participation has enabled critical self insight of our PV operations and strategy. pvnet is a forum that develops, rather than just tracks industry trends."John Freeman, Head of Worldwide Drug Safety, Celgene
|
|
|
|
|
|